KATHRYN LAZURE: Open Payments
NPI 1649744244 · PRAIRIE GROVE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 16 payments from 8 companies in 2025. Trend: 2023 $362 · 2024 $130 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $114 |
| ABBVIE INC. | 3 | $93 |
| Neurocrine BioSciences, Inc. | 4 | $73 |
| Alkermes, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| PFIZER INC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: HETLIOZ, VRAYLAR, INGREZZA, VIVITROL, CAPLYTA, PREVNAR 20, Ozempic, BREZTRI.
Industry payments across AR — which companies pay providers there.
